Copyright © 1996, 2001 by Galen Daryl Knight and VitaleTherapeutics, Inc.

Vitaletheine Analogues

Monooxygenase substrates distinctly different from the vitaletheine modulators are known to be carcinogenic. It is unclear at this time whether they block interactions of the vitaletheine modulators ("the right key") with the monooxygenase ("the lock"), or with other receptors ("locks"), or if they chemically react with or inactivate ("bend") these important sulfur compounds so that they can no longer function properly on their appropriate receptor ("lock").


Home Overview People Journal Nutrition
WWW Links Outline e-mail us